You are here: Home » International » News » Companies
Business Standard

Investors ready to resuscitate Johnson & Johnson's ailing stock

J&J's medical devices segment including its orthopaedics business has been losing market share

Reuters  |  New York 

Johnson & Johnson shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalising on the stock's relatively cheap valuation may be set to apply a Band-Aid to the declines. Shares of J&J, the largest U.S. healthcare company by market value, had slumped 11.2 per cent this year as of Friday's close, although recent gains may indicate the start of a rebound. The stock's year-to-date decline compares to more than 2 per cent gains for both the S&P 500 healthcare sector and the blue-chip Dow Jones Industrial Average, of ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, June 12 2018. 07:20 IST